Low Environmental pH Is Responsible for the Induction of Nitric-oxide Synthase in Macrophages
EVIDENCE FOR INVOLVEMENT OF NUCLEAR FACTOR-kappa B ACTIVATION*

Agnès BellocqDagger , Sidonie SubervilleDagger , Carole PhilippeDagger , France Bertrand§, Joëlle PerezDagger , Bruno FouquerayDagger , Gisèle Cherqui§, and Laurent BaudDagger

From the Dagger  INSERM U. 64, Hôpital Tenon, 75020 Paris and § INSERM U. 402, Hôpital Saint-Antoine, 75012 Paris, France

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Stimulation of macrophages with endotoxin and/or cytokines is responsible for the expression of the inducible isoform of nitric oxide synthase (iNOS). Because macrophages are exposed to low pH within the microenvironment of inflammatory lesions, the potential role of acidic pH as an additional regulator of iNOS was investigated. Substitution of the culture medium of rat peritoneal macrophages at pH 7.4 with medium at pH 7.0 up-regulated iNOS activity, as reflected by a 2.5-fold increase in nitrite accumulation. The increase in iNOS activity was associated with a similar increase in iNOS mRNA expression that reflected an increase in iNOS mRNA synthesis rather than stability. Low environmental pH-induced iNOS gene transcription involved the activation of nuclear factor-kappa B (NF-kappa B) transcription factor since exposure of macrophages to low environmental pH both increased NF-kappa B binding activity in the nucleus and enhanced NF-kappa B-driven reporter gene expression. In addition, treatment of macrophages with pyrrolidine dithiocarbamate or n-acetyl-leucinyl-leucinyl-norleucinal, two drugs preventing NF-kappa B translocation to the nucleus, canceled low pH-induced nitrite accumulation. The overall mechanism required the synthesis of tumor necrosis factor alpha  (TNFalpha ). Indeed, 1) elevated TNFalpha bioactivity was observed in the medium of macrophages exposed to pH 7.0, and 2) incubation of macrophages with a neutralizing anti-TNFalpha antibody impaired both NF-kappa B activation and nitrite accumulation in response to acid challenge. In summary, exposure of macrophages to acidic microenvironment in inflammatory lesions leads to the up-regulation of iNOS activity through the activation of NF-kappa B.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Acidosis is a hallmark of both ischemia and inflammation processes. The decrease of pH in tissue ischemia is secondary to the release of H+ during ATP hydrolysis and to the accumulation of CO2 (1). The acidic environment in inflammatory lesions and abscesses (2) is due to increased metabolic acid generation during cell activation. This originates primarily from the hexose monophosphate shunt, by the dissociation of hydrated CO2 (3).

In most cases, acidosis occurs along with nitric oxide (NO)1 generation. In ischemia, NO generation is due in one part to the acidification and reduction of the large pool of nitrite present within the tissue (4). In inflammatory processes, macrophage exposure to bacterial lipopolysaccharide (LPS) or cytokines such as tumor necrosis factor alpha  (TNFalpha ) and interferon-gamma (IFN-gamma ) causes the expression of the inducible isoform of NO synthase (NOS II or iNOS) that is responsible for high output production of NO (5). The expression of iNOS is regulated mainly at the transcriptional level. Analyses of the murine iNOS promoter have shown the presence of numerous consensus sequences for the binding of transcription factors (6, 7), of which nuclear factor-kappa B (NF-kappa B) (8), interferon regulatory factor-1 (IRF-1) (9), and signal transducer and activator of transcription (STAT) 1alpha (10) are functionally important for iNOS induction. NF-kappa B is composed of a p50/p65 (or p50/RelA) heterodimer that is retained in the cytoplasm of macrophages by its binding to the inhibitory protein Ikappa Balpha (11). Macrophage exposure to LPS or TNFalpha results in the rapid phosphorylation of Ikappa Balpha and its degradation by the proteasome, allowing NF-kappa B to translocate to the nucleus and promote iNOS gene transcription.

Whether an acidic environment beside LPS and cytokines contributes to the regulation of iNOS in inflammatory processes has not been investigated. Thus, the experiments reported here were performed to investigate if a low environmental pH was able to activate iNOS in macrophages and, if so, to examine the signal transduction pathway involved. Our results provide the first evidence that, indeed, limited acidification of macrophage environment is sufficient to induce the expression of iNOS gene and the synthesis of NO. This effect is due to increased translocation of NF-kappa B to the nucleus. Additionally, our data show that an amplification loop involving TNFalpha production and NF-kappa B activation is required for this process.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cell Isolation and Culture-- Resident macrophages were obtained from male Sprague-Dawley rats by peritoneal lavage with MEM (Life Technologies, Inc., Cergy Pontoise, France). Peritoneal cells were washed by centrifugation and then resuspended in MEM containing 2 mM L-glutamine, 100 units/ml penicillin, and 100 µg/ml streptomycin and supplemented with 10% FCS. Cells were plated either in 24-well culture plates (Costar, Cambridge, MA) (106 cells in 0.5 ml/well) or in 60-mm Petri dishes (Nunc, Roskilde, Denmark) (107 cells in 5 ml). After a 2-h incubation at 37 °C in a 5% CO2, 95% air atmosphere, the nonadherent cells were removed by aspiration, and the macrophage monolayers were then overlaid with MEM supplemented with 1% FCS and adjusted by addition of HCl to pH ranging between 7.4 and 6.8. The pH of the culture medium was checked just before use. In addition, and when so indicated, culture media were supplemented with 5-(N,N-hexamethylene) amiloride (HMA, LC Services, Woburn, MA), monensin, actinomycin D, 5,6-dichloro-1-beta -D-ribofuranosyl benzimidazole (DRB), pyrrolidine dithiocarbamate (PDTC), or n-acetyl-leucinyl-leucinyl-norleucinal (nor-LEU) (all from Sigma) or anti-murine TNFalpha neutralizing antibody (106 neutralizing units/ml; Genzyme, Cambridge, MA). At indicated times, cell-free culture supernatants were harvested and assayed for nitrite concentration. Adherent cells were used for nucleus or RNA extraction.

RAW 264.7 cells (American Type Culture Collection) were grown in DMEM (Life Technologies, Inc.) supplemented with 10% FCS and antibiotics at 37 °C in a 5% CO2, 95% air atmosphere.

Determination of Intracellular pH in Macrophages-- Macrophages at 107 cells/ml were washed twice with MEM and loaded with the acetoxymethyl ester of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF, Sigma) at 10 µM by incubation at 37 °C for 10 min. Cells were washed twice, and the cell suspension was immediately analyzed in a Perkin-Elmer model LS-5 spectrofluorometer for the fluorescence of BCECF. The sample was alternately excited at 450 and 500 nm, and the emission was measured at 530 nm using 2.5-nm slits. At the end of each experimental procedure, the cells were permeabilized with 0.05% (v/v) Triton X-100, and aliquots of the suspension were titrated with 1 N HCl and 1 N NaOH to establish the fluorescence at known pH values. Calibration curves of fluorescence versus pH were obtained as described previously (12).

Determination of iNOS Activity-- Inducible NOS activity was assayed indirectly by measuring nitrite production. Nitrite was measured by a colorimetric assay based on the Griess reaction, as described previously (13). Briefly, 75-µl aliquots of macrophage-conditioned medium were incubated with 150-µl aliquots of Griess reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride, 2.5% H3PO4). The absorbance was read at 540 nm after 15 min. Nitrite concentration was determined with reference to a standard curve by using concentrations from 1.5 to 50 µM sodium nitrite in culture media.

Semi-quantitative RT-PCR and Analysis of PCR Products-- Total RNA was isolated using a commercially available kit (Trizol reagent, Life Technologies, Inc.) according to the manufacturer's instructions. One µg of total RNA was reverse-transcribed to cDNA by using Moloney murine leukemia virus-reverse transcriptase (200 units/µl; Life Technologies, Inc.). Reverse-transcribed samples were analyzed for iNOS and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific cDNA by PCR amplification. Specific primers for iNOS and GAPDH were as follows: CACAAGGCCACATCGGATTTC (sense) and TGCATACCACTTCAACCCGAG (antisense); TCCCTCAAGATTGTCAGCAA (sense) and AGATCCACAA CGGATACATT (antisense), respectively (14). PCR was performed in a 50-µl reaction volume containing Taq polymerase buffer, deoxynucleotide mixture (0.2 mM each), MgCl2 (1.5 mM), Taq DNA polymerase (2.5 units) (Promega, Southampton, UK), oligonucleotide primers (0.5 µM each), and reverse-transcribed RNA. Complementary DNA was amplified in a temperature cycler as follows: 4 min at 94 °C, and 30-32 cycles of 30 s at 94 °C, 1 min at 55 °C, and 2 min at 72 °C, with a final extension step of 10 min at 72 °C. Thirty and 32 PCR cycles were found in the exponential phase of PCR amplification of GAPDH and iNOS cDNA, respectively. Ten-µl samples of PCR products were analyzed on 1.7% agarose gels containing 0.2 µg/ml ethidium bromide. Densitometry of the bands was performed on the gels using an Imager scanner (Appligene, Illkirch, France) and NIH image densitometry software (version 1.44).

Enzyme-linked Immunosorbent Assay-PCR-- Quantitative PCR amplification was carried out with a pair of primers of which one was biotinylated (15). Specific primers for iNOS and GAPDH were GGAGCTGTAGCACTGCATCAGAA (sense), AGACCTCTGGATCTTGACCGTGA (antisense), and GGTGAAGGTCGGTGTCAACGGA (sense), GCGGGATCGCGCTCCTGGAAGA (antisense), respectively. PCR was performed in a 50-µl reaction volume containing Taq polymerase buffer, deoxynucleotide mixture (0.2 mM each), MgCl2 (1.5 mM), Taq DNA polymerase (1.25 units) (Promega) preincubated with Taq Start antibody (0.125 µl) (CLONTECH, Palo Alto, CA), oligonucleotide primers (0.25 µM each), and reverse-transcribed RNA. Temperature was initially at 94 °C for 4 min, followed by cycles at 94 °C for 20 s, 60 °C for 40 s, and 72 °C for 40 s. At sequential cycle numbers, 5 µl of the reaction mixture was taken through oil and transferred onto avidin-coated microtiter plates for quantification of the amplified products by hybridization with a fluorescein isothiocyanate-labeled internal oligonucleo tide probe. Specific probes for iNOS and GAPH were CGCTTCGATGTGCTGCCT and AGAAGGCAGCCCTGGTGA, respectively. The amount of probe was then measured by an alkaline-phosphatase coupled anti-fluorescein isothiocyanate antibody (16).

Electrophoretic Mobility Shift Assay (EMSA)-- Nuclear extracts were prepared from adherent macrophages by the method previously described (17) and were stored at -80 °C until analysis. Protein was determined by using the Bio-Rad reagent according to the manufacturer's instructions. Where indicated, nuclear extracts were incubated for 30 min at 4 °C with polyclonal antibodies against p50 or RelA subunits of NF-kappa B (Santa Cruz Biotechnology, Santa Cruz, CA), before the binding reaction. The double-stranded NF-kappa B site probe: 5'-AGCTTCAGAGGGGACTTTCCGAGAGG-3'; 3'-AGTCTCCCCTGAAAGGCTCTCCA GCT-5' (18), double-stranded IFN regulatory factor element (IRF-E) probe: 5'-CACTGTCAATATTTCAC-3'; 3'-GACAGTTATAAAGTGAAAGTATTA-5' (9), double-stranded gamma -activated site (GAS) probe: 5'-TGTTTGTTCCTTTTCCCCTAACA-3'; 3'-GGAAAAGGGGATTGTGAC-5' (9) and double-stranded activator protein 1 (AP-1) site probe: 5'-AGCTAGGTGACTCACCAAGCT-3'; 3'-TCCACTGAGTGG TTCGAAGCT-5' (19) were annealed and labeled using a commercially available kit (Rediprime DNA labeling system, Amersham Corp., Buckinghamshire, UK) in the presence of 50 µCi of [alpha -32P]dCTP (10 mCi/ml, Amersham Corp.). Unincorporated nucleotides were removed by passage through Nuctrap purification columns (Stratagene, La Jolla, CA). Binding reactions were carried out in a 20-µl binding reaction mixture (10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 0.5 mM dithiothreitol, 10% glycerol, 0.2% Nonidet P-40, and 3 µg of poly(dI-dC)) containing 5-10 µg of nuclear proteins and the DNA probe (40,000-200,000 cpm). In some experiments, the binding reaction mixture also contained a large excess of unlabeled oligonucleotides. Samples were incubated at room temperature for 25 min and fractionated by electrophoresis on a 7% non-denaturing polyacrylamide gel in TAE buffer (7 mM Tris, pH 7.5, 3 mM sodium acetate, 1 mM EDTA), which had been pre-electrophoresed for 1 h at 80 V. Gels were run at 160 V for 2.5 h. Following electrophoresis, gels were transferred to No. 3MM paper (Whatman Ltd.), dried in a gel dryer under vacuum at 80 °C, and exposed to x-ray Hyperfilm-MP at -20 °C using an intensifying screen.

Transient Transfection of RAW 264.7 Cells and Luciferase Assay-- RAW 264.7 cells were transfected with (Igkappa )3-conaluc, a reporter plasmid that contains three copies of the immunoglobulin kappa  chain enhancer kappa B site upstream of the minimal conalbumin promoter fused to the luciferase reporter gene (generous gift from Dr. A. Israel, Institut Pasteur, Paris, France), using the DEAE-dextran procedure (6, 20). Briefly, after cells were washed with Tris-buffered saline solution, 10 µg of plasmid was added per 107 cells in 1 ml of warm Tris-buffered saline solution containing 250 µg of DEAE-dextran. The cells were incubated at 37 °C for 1 h followed by a 2-min shock with 10% Me2SO at room temperature. The cells were washed twice, plated in 35-mm plates at 2.5 × 106 cells/ml in 2 ml of DMEM supplemented with 10% FCS at 37 °C in 5% CO2. Twenty-four h later, the medium was replaced with DMEM supplemented with 1% FCS and adjusted at different pH, and the cells were incubated for additional 2 h. The cells were then washed, exposed for 15 min to chilled lysis buffer (25 mM Tris, pH 7.8, 10 mM MgCl2, 1 mM EDTA, 1 mM dithiothreitol, 1% Triton X-100, and 15% glycerol), and scraped. The lysates were centrifuged at 13,000 × g for 10 min. Luciferase activity was assayed in lysis buffer containing 50 mM ATP and 100 µM luciferin, using a Lumat LB 9507 luminometer (Berthold Bad Wildbad, Germany) (17).

Determination of TNFalpha Production-- The concentration of bioactive TNFalpha in the culture medium of macrophages was measured by a L-929 fibroblast lytic assay, as described previously (21). Results were expressed as percent cytotoxicity.

Statistics-- Results are presented as the mean ± S.E. Statistical significance (p < 0.05) was determined by Student's t test.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Macrophages Exposed to Low Environmental pH Demonstrate Increased iNOS Activity-- Substitution of the medium of adherent macrophages with media at different pH modified iNOS activity as reflected by changes in nitrite accumulation; as the environmental pH became more acidic, more nitrite was detected in the culture media (Fig. 1). Its amount plateaued at pH 6.9-7.0. Because modification of the microenvironmental pH generally induces parallel modification of the steady-state intracellular pH (22), involvement of intracellular acidification in this process was tested. First, intracellular pH decreased from 7.04 ± 0.03 to 6.77 ± 0.01 after lowering environmental pH from 7.4 to 6.9-7.0, as measured fluorimetrically with the H+ indicator dye BCECF. Second, pharmacological control of the Na+/H+ antiport, which exchanges extracellular Na+ for intracellular H+, caused measurable changes in NO synthesis. As indicated in Fig. 2, the addition of the amiloride analog HMA, a Na+/H+ exchange inhibitor which decreases intracellular pH (23), caused a dose-dependent increase in nitrite accumulation. Conversely, the addition of monensin, a Na+ ionophore mimicking the effects of the antiporter activation (24), caused a dose-dependent decrease in nitrite accumulation. These results suggested that intracellular acidification was sufficient to trigger NO synthesis.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of environmental pH on nitrite accumulation in culture medium of macrophages. Adherent macrophages were cultured for 18 h in MEM adjusted at indicated pH. Nitrite content of culture supernatant samples was assessed using the Griess reagent. Results are expressed as the mean ± S.E. of eight separate experiments. *, p < 0.05 as compared with pH 7.4.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of Na+/H+ exchange on nitrite accumulation in the culture medium of macrophages. Adherent macrophages were treated with the indicated concentrations of HMA (black-square) or monensin () for 18 h, before nitrite analysis was performed. Results are expressed as the mean ± S.E. of five separate experiments. *, p < 0.05 as compared with untreated macrophages.

Inducible NOS is susceptible to control mainly at the transcriptional level (6, 7). Thus DRB, a specific RNA polymerase II inhibitor, was used to determine to what extent nitrite accumulation in response to low environmental pH was due to increased transcription of the iNOS gene. Pretreatment of macrophages with this drug reduced nitrite accumulation in the macrophage culture medium adjusted at pH 7.4 and blunted the response to acid challenge (Fig. 3A). To confirm the involvement of increased expression of the iNOS gene, semi-quantitative RT-PCR was first performed. A detectable expression of the iNOS mRNA was always observed in control macrophages, as described previously (25) (Fig. 3B). Exposure of cells to low environmental pH determined a marked increase in this mRNA expression. The amount of iNOS mRNA quantified by densitometry and expressed as iNOS/GAPDH ratio was 0.76 ± 0.11 and 1.75 ± 0.08 for macrophages exposed to culture medium at pH 7.4 and 7.0, respectively (p < 0.01, n = 3). For further verification, quantitative RT-PCR was performed (Fig. 3C). The amount of iNOS mRNA was sharply increased in cells exposed to acidic pH as judged by the difference in the number of amplification cycles necessary to generate similar amounts of PCR products. Next, iNOS mRNA stability was assessed in actinomycin D experiments. After exposure to media at different pH for 1 h, macrophages were treated with actinomycin D to inhibit further transcription. At various times after the addition of actinomycin D, total RNA was isolated and examined by enzyme-linked immunosorbent assay-PCR (Fig. 3C). The decay of iNOS mRNA, which was revealed by a shift to the right of OD curves, was enhanced in cells exposed to acidic pH. Thus low environmental pH increased iNOS mRNA expression by up-regulating its synthesis rather than its stability.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Nitrite accumulation in response to low environmental pH is due to increased transcription of the iNOS gene. A, effect of DRB, a specific RNA polymerase II inhibitor, on nitrite accumulation in culture medium of macrophages. Adherent macrophages were treated with () or without (black-square) 60 µM DRB for 18 h before nitrite analysis was performed. Results are expressed as the mean ± S.E. of determinations from four separate experiments. *, p < 0.05 as compared with pH 7.4. B, effect of environmental pH on the steady-state levels of iNOS and GAPDH mRNAs in macrophages. Adherent macrophages were cultured in MEM adjusted at indicated pH for 3 h before semi-quantitative RT-PCR analysis was performed. Results are representative of three individual experiments. C, effect of environmental pH on the synthesis and stability of iNOS and GAPDH mRNAs in macrophages. Adherent macrophages were cultured for 1 h in MEM adjusted at pH 7.4 (square ) or 7.0 (black-square) before the addition of actinomycin D (5 µg/ml). RNA was sampled at the indicated times, and quantitative RT-PCR analysis was performed. Results are representative of two individual experiments.

Low Environmental pH Response Is Due to the Activation of NF-kappa B-- The 5'-flanking region of mouse iNOS gene contains numerous consensus sequences for the binding of transcription factors, including NF-kappa B, IRF-1, STAT 1alpha , and AP-1 (6, 7). Therefore, it is possible that low environmental pH stimulates iNOS gene transcription by modulating the activity of some of these factors. To test the above hypothesis, the effect of extracellular pH on the DNA binding activity of these transcription factors was measured by EMSA. Nuclear extracts from control macrophages cultured at neutral environmental pH exhibited weak DNA binding activity to the NF-kappa B site-containing oligonucleotide (Fig. 4A). As the environmental pH became more acidic, more binding activity of NF-kappa B was detected. At pH 7.0, NF-kappa B activation was similar to that promoted by LPS challenge. By contrast, acidic pH did not affect DNA binding activity of IRF-1, STAT 1alpha , or AP-1, whereas LPS was stimulatory (Fig. 4B).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 4.   A, effect of environmental pH on the nuclear expression of NF-kappa B in macrophages. Adherent macrophages were cultured in MEM adjusted at indicated pH for 2 h. Nuclear extracts from these cells were then analyzed for NF-kappa B DNA binding activities by EMSA (left panel). The binding reaction was also carried out after a 30-min incubation with or without anti-p50 and anti-RelA antibodies (right panel). Results are representative of four individual experiments. B, effect of environmental pH on the nuclear expression of IRF-1, STAT 1alpha , and AP-1 in macrophages. Adherent macrophages were cultured in MEM adjusted at indicated pH for 2 h. Nuclear extracts from these cells were then analyzed for IRF-1, STAT 1alpha , and AP-1 DNA binding activities by EMSA. Results are representative of two to four individual experiments.

The specificity of low pH-induced bands was assessed in competition experiments. These bands disappeared in the presence of the unlabeled oligonucleotide containing the NF-kappa B binding sites (Fig. 4A). We further characterized the two NF-kappa B·DNA complexes by using antibodies directed against the p50 and RelA NF-kappa B subunits (Fig. 4A). Incubation of macrophage nuclear extracts with the anti-p50 antibody reduced the density of both bands with a concomitant supershift suggesting the presence of p50 in the two complexes. The anti-RelA antibody suppressed the upper band suggesting the presence of RelA. Thus we identified the lower and upper complexes as the p50 homodimer and the p50/RelA heterodimer, respectively.

To test whether low extracellular pH enhanced NF-kappa B-driven reporter gene expression, RAW 264.7 cells were transfected transiently with (Igkappa )3-conaluc, a reporter plasmid in which the activity of the minimal conalbumin promoter could be enhanced by three copies of the NF-kappa B response element (17). Luciferase activity from such transfected cells after exposure to media at different pH is shown in Fig. 5; low pH stimulation of luciferase activity was analogous to that of nitrite accumulation under the same conditions.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of environmental pH on NF-kappa B-dependent luciferase reporter gene expression. RAW 264.7 cells were transfected by a DEAE-dextran method with 10 µg of the luciferase reporter plasmid (Igkappa )3-conaluc. Twenty-four h after transfection, the cells were exposed to DMEM adjusted at indicated pH. After 2 h, the cells were lysed and assayed for luciferase activity. Results are from one representative experiment from three performed.

The contribution of NF-kappa B in low pH-induced iNOS up-regulation was investigated using two inhibitors of NF-kappa B activation in macrophages as follows: the thiol compound PDTC, a radical scavenger (26), and the peptide aldehyde nor-LEU, a proteasome inhibitor (27). Addition of either drug blunted the macrophage response to low environmental pH (Fig. 6).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of NF-kappa B inhibitors PDTC and nor-LEU on low environmental pH-induced accumulation of nitrites in culture medium of macrophages. Adherent macrophages were cultured for 18 h in MEM adjusted at indicated pH in the absence of inhibitor (black-square) or in the presence of either 100 µM PDTC () or 5 µM nor-LEU (square ), before nitrite analysis was performed. Results are expressed as the mean ± S.E. of seven separate experiments. *, p < 0.05 as compared with pH 7.4.

Low Environmental pH-induced NF-kappa B Activation Requires the Autocrine Production of TNFalpha -- Because NF-kappa B initiates the transcription of a variety of genes that are all involved in inflammatory processes, it is likely that low environmental pH-induced NF-kappa B activation amplifies the synthesis of pro-inflammatory cytokines beside that of iNOS. To address this issue, the capacity of macrophages exposed to acidic pH to release bioactive TNFalpha was determined. Fig. 7 shows that a decrease in environmental pH from 7.4 to 7.0 caused a 1.8-fold increase in TNFalpha release. PDTC blunted this response. We next evaluated whether the rise of TNFalpha level in the culture medium of macrophages was involved in the observed increase in nitrite accumulation. To this end, a neutralizing anti-TNFalpha antibody diluted at 1/100 was added to the culture medium. This concentration was sufficient to totally inactivate the TNFalpha released by macrophages (data not shown). Anti-TNFalpha both prevented the activation of NF-kappa B and suppressed the accumulation of nitrites (Fig. 8), indicating that an autocrine loop involving TNFalpha induction of NF-kappa B was responsible for the induction of iNOS by low environmental pH.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of environmental pH on TNFalpha synthesis by macrophages. Adherent macrophages were cultured for 18 h in MEM adjusted at indicated pH and supplemented with () or without (black-square) 100 µM PDTC. The TNFalpha content of culture supernatant samples was assessed using specific bioassay. Results are expressed as mean ± S.E. of five separate experiments. *, p < 0.05 as compared with pH 7.4.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 8.   Activation of NF-kappa B and iNOS in response to low environmental pH requires the autocrine production of TNFalpha . A, effects of anti-TNFalpha antibody on NF-kappa B activation. Adherent macrophages were cultured for 2 h in MEM adjusted at indicated pH and supplemented with or without anti-TNFalpha neutralizing antibody, before NF-kappa B activity was assayed. Results are representative from two individual experiments. B, effects of anti-TNFalpha antibody on nitrite accumulation. Adherent macrophages were cultured for 18 h in MEM adjusted at indicated pH and supplemented with () or without (black-square) anti-TNFalpha neutralizing antibody, before nitrite analysis was performed. Results are expressed as mean ± S.E. of 10 separate experiments.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Our results provide evidence that low environmental pH stimulates NO synthesis by macrophages and, more specifically, up-regulates iNOS mRNA expression. These responses were observed for a range of extracellular pH values occurring in inflammatory lesions (2). The decrease in intracellular pH in macrophages exposed to low environmental pH and the increase in nitrite accumulation in the culture medium of macrophages treated by the amiloride analog HMA indicate that acidic intracellular pH is involved in triggering NO synthesis. Since NO has been shown to impair intracellular pH recovery in macrophages following acid loading (28), an amplification loop involving low pH induction of NO synthesis is likely in these cells.

The mechanisms responsible for low pH-induced NO synthesis are potentially numerous. First, changes in pH might affect the activity of the enzyme iNOS. Indeed, in vitro analysis has shown that iNOS activity was pH-dependent (29). However, the optimum activity was reached at pH 8.0, whereas reduced activity occurred at acidic pH. Second, a low environmental pH might influence the availability of substrates such as L-arginine and cofactors necessary for NO production. However, L-arginine and its precursor, L-citrulline, are transported by pH-insensitive specific carriers (30). In fact, the main rate-limiting step for NO production by macrophages in low environmental pH is transcriptional since DRB blunted this response. The possibility that pH controls the transcription of genes has been demonstrated previously. For instance, Yamaji et al. (31) reported that exposure of epithelial cells from mouse proximal tubule to an acid environment led to transcriptional activation of immediate early genes such as c-fos and c-jun. Similarly, an acute decrease in extracellular pH from 7.4 to 6.9 caused a marked increase in the expression of mRNA for phosphoenolpyruvate carboxykinase in epithelial cells from pig proximal tubule (32).

Transcription factors such as NF-kappa B (8), IRF-1 (9, 33), and STAT 1alpha (10) underlie the synergistic activation of the promoter of the murine iNOS gene in response to LPS and IFN-gamma . Thus, we directly assessed the ability of environmental pH to control the induction or the activation of these factors. By using an EMSA we observed that low environmental pH increased the DNA binding activity of NF-kappa B. The stimulatory effect was specific for NF-kappa B since the DNA binding activity of IRF-1 and STAT 1alpha was not modified under these conditions. Dose-response experiments indicated a biphasic effect. A slightly acidic environment (7.2 to 6.9) amplified NF-kappa B activation (Fig. 4A), whereas a more acidic environment (below 6.9) reduced NF-kappa B activation (data not shown). The inhibitory effect of marked acidosis on NF-kappa B activation has already been demonstrated (34). Taken together, these results suggest that weak acidosis in settling inflammation may amplify NF-kappa B-dependent iNOS expression, resulting in a more efficient defense against bacteria. Once acid generation is high, protons may limit the induction of iNOS and prevent its toxicity toward the surrounding tissue.

The mechanisms whereby low environmental pH increases NF-kB activation may include up-regulation of NF-kappa B synthesis and/or down-regulation of NF-kappa B degradation and/or reduction of NF-kappa B binding to cytosolic Ikappa B. Acidic pH could potentially alter the linkage between NF-kappa B and Ikappa B without modifying Ikappa B phosphorylation or degradation (11). However, the fact that the low environmental pH responses could be abrogated by addition of PDTC or nor-LEU is consistent with the involvement of Ikappa B degradation. Indeed, both drugs prevent Ikappa B inactivation as follows: PDTC, as other antioxidants, limits Ikappa B phosphorylation and nor-LEU, as other proteasome inhibitors, inhibits Ikappa B degradation but not phosphorylation (27). Furthermore, the results of experiments with nor-LEU suggest that low environmental pH induces NF-kappa B activation by promoting Ikappa B degradation via the ubiquitin-proteasome pathway. Our study did not address the relationship between environmental pH and expression of proteins involved in this pathway. However, Bailey et al. (35) recently reported that acidosis in chronic renal failure stimulated muscle proteolysis by activating the ATP-ubiquitin-proteasome-dependent pathway. This response included increased transcription of genes encoding ubiquitin and proteasome subunits C3 and C9. Thus, further studies would be required to determine whether low environmental pH induces NF-kappa B activation in macrophages by these mechanisms.

In addition, a possibility to explain the in vivo effect of low pH on the transcription step is that acidosis could directly affect the binding of NF-kappa B subunits to DNA. However, this is unlikely. Indeed, studies by Zabel et al. (18) have demonstrated that NF-kappa B could form a complex with DNA within a large pH range, the highest amount of protein-DNA complex being formed at the physiological pH of 7.5.

The NF-kappa B transcription factor regulates the transcription of a great variety of genes that are involved in inflammatory responses. They include genes coding for cytokines such as IFN-beta , interleukin-1, -2, -6, and -8, granulocyte/macrophage or granulocyte colony-stimulating factor, TNFalpha , as well as genes coding for acute phase response proteins and cell adhesion molecules (reviewed in Ref. 36). One could speculate that transcription of these genes might be similarly susceptible to induction by low environmental pH. Accordingly, acidosis was found to potentiate TNFalpha synthesis by macrophages (Fig. 7). We addressed the issue of whether low environmental pH-induced TNFalpha synthesis was in turn responsible for NO synthesis by using a neutralizing antibody specific for TNFalpha (Fig. 8). This antibody blunted both NF-kappa B activation and nitrite accumulation. Thus, TNFalpha appears to be involved in NF-kappa B activation which eventually leads to iNOS gene transcription. A similar amplification loop involving TNFalpha induction of NF-kappa B has been already described. For instance, O'Connell et al. (37) demonstrated that the proliferation rate of cells derived from a Sezary lymphoma was stimulated by the autocrine production of TNFalpha . This response resulted from the activation of NF-kappa B which also led to further TNFalpha production.

In summary, in addition to hypoxia (38), LPS, and cytokines (5), low environmental pH causes amplification of NO synthesis in inflammatory tissues. Evidence that this up-regulation is mediated through the activation of NF-kappa B suggests a novel mechanism whereby the nuclear translocation of this transcription factor may be triggered. Our studies also suggest that correction of acidosis in inflammatory processes may have a therapeutic role by limiting the transcription of cytokine genes with a conserved NF-kappa B binding site in the promoter.

    ACKNOWLEDGEMENTS

We thank Valerie Miranda and Nelly Knobloch for secretarial assistance.

    FOOTNOTES

* This work was supported by INSERM and the Faculté de Médecine Saint-Antoine.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: INSERM U.64, Hôpital Tenon, 4 rue de la Chine, 75020 Paris, France. Tel.: 33 1 40 30 79 51; Fax: 33 1 40 30 20 89; E-mail: laurent.baud{at}tnn.ap-hop-paris.fr.

1 The abbreviations used are: NO, nitric oxide; AP-1, activator protein 1; EMSA, electrophoretic mobility shift assay; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HMA, 5-(N,N-hexamethylene) amiloride; iNOS, inducible NO synthase; NF-kappa B, nuclear factor-kappa B; nor-LEU, n-acetyl-leucinyl-leucinyl-norleucinal; PDTC, pyrrolidine dithiocarbamate; TNFalpha , tumor necrosis factor alpha ; DMEM, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; RT-PCR, reverse transcriptase-polymerase chain reaction; STAT, signal transducer and activator of transcription; IFN, interferon; LPS, lipopolysaccharide; BCECF, 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein; MEM, minimum Eagle's medium; IRF-1, interferon regulatory factor-1; DRB, 5,6-dichloro-1-beta -D-ribofuranosyl benzimidazole.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Weinberg, J. M. (1991) Kidney Int. 39, 476-500[Medline] [Order article via Infotrieve]
  2. Bryant, R. E., Rashad, A. L., Mazza, J. A., Hammond, D. (1980) J. Infect. Dis. 142, 594-601[Medline] [Order article via Infotrieve]
  3. Wright, J., Schwartz, J. H., Olson, R., Kosowsky, J. M., Tauber, A. I. (1986) J. Clin. Invest. 77, 782-788[Medline] [Order article via Infotrieve]
  4. Zweier, J. L., Wang, P., Samouilov, A., and Kuppusamy, P. (1995) Nat. Med. 1, 804-809[Medline] [Order article via Infotrieve]
  5. Nathan, C. (1992) FASEB J. 6, 3051-3064[Abstract/Free Full Text]
  6. Xie, Q.-W., Whisnant, R., and Nathan, C. (1993) J. Exp. Med. 177, 1779-1784[Abstract]
  7. Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., Murphy, W. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9730-9734[Abstract]
  8. Xie, Q.-W., Kashiwabara, Y., and Nathan, C. (1994) J. Biol. Chem. 269, 4705-4708[Abstract/Free Full Text]
  9. Martin, E., Nathan, C., and Xie, Q.-W. (1994) J. Exp. Med. 180, 977-984[Abstract]
  10. Gao, J., Morrison, D. C., Parmely, T. J., Russell, S. W., Murphy, W. J. (1977) J. Biol. Chem. 272, 1226-1230[Abstract/Free Full Text]
  11. Grimm, S., and Bauerle, P. A. (1993) Biochem. J. 290, 297-308[Medline] [Order article via Infotrieve]
  12. Baud, L., Healy, A., Cragoe, E. J., Goetzl, E. J., Koo, C. H. (1988) J. Cell. Physiol. 136, 355-360[Medline] [Order article via Infotrieve]
  13. Boutard, V., Havouis, R., Fouqueray, B., Philippe, C., Moulinoux, J.-P., and Baud, L. (1995) J. Immunol. 155, 2077-2084[Abstract]
  14. Liu, S., Adcock, I. M., Old, R. W., Barnes, P. J., Evans, T. W. (1993) Biochem. Biophys. Res. Commun. 196, 1208-1213[CrossRef][Medline] [Order article via Infotrieve]
  15. Lantz, O., and Bendelac, A. (1994) J. Exp. Med. 180, 1097-1106[Abstract]
  16. Alard, P., Lantz, O., Sebagh, M., Calvo, C. F., Weill, D., Chavanel, G., Senik, A., Charpentier, B. (1993) BioTechniques 15, 730-737 [Medline] [Order article via Infotrieve]
  17. Bertrand, F., Philippe, C., Antoine, P. J., Baud, L., Groyer, A., Capeau, J., Cherqui, G. (1995) J. Biol. Chem. 270, 24435-24441[Abstract/Free Full Text]
  18. Zabel, U., Schreck, R., and Bauerle, P. A. (1991) J. Biol. Chem. 266, 252-260[Abstract/Free Full Text]
  19. Demczuk, S., Harbers, M., and Vennström, B. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2574-2578[Abstract]
  20. Selden, R. F. (1996) in Current Protocols in Molecular Biology (Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., eds), pp. 9.2.1-9.2.6, John Wiley & Sons, Inc., New York
  21. Philippe, C., Philippe, B., Fouqueray, B., Perez, J., Lebret, M., and Baud, L. (1993) Am. J. Pathol. 143, 1713-1723[Abstract]
  22. Mellergård, P., Ou-Yang, Y., and Siesjö, B. K. (1994) Am. J. Physiol. 267, C581-C589[Abstract/Free Full Text]
  23. Baud, L., Perez, J., Cherqui, G., Cragoe, E. J., Ardaillou, R. (1989) Am. J. Physiol. 257, C232-C239[Abstract/Free Full Text]
  24. Ghigo, D., Bussolino, F., Garbarino, G., Heller, R., Turrini, F., Pescarmona, G., Cragoe, E. J., Jr., Pegoraro, L., Bosia, A. (1988) J. Biol. Chem. 263, 19437-19446[Abstract/Free Full Text]
  25. Chesrown, S. E., Monnier, J., Visner, G., and Nick, H. S. (1994) Biochem. Biophys. Res. Commun. 200, 126-134[CrossRef][Medline] [Order article via Infotrieve]
  26. Schreck, R., Rieber, P., and Bauerle, P. A. (1991) EMBO J. 10, 2247-2258[Abstract]
  27. Griscavage, J. M., Wilk, S., and Ignarro, L. J. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 3308-3312[Abstract/Free Full Text]
  28. Swallow, C. J., Grinstein, S., Sudsbury, R. A., Rotstein, O. D. (1991) J. Exp. Med. 174, 1009-1021[Abstract]
  29. Yaqoob, M., Edelstein, C. L., Wieder, E. D., Alkhunaizi, A. M., Gengaro, P. E., Nemenoff, R. A., Schrier, R. W. (1996) Kidney Int. 49, 1314-1319[Medline] [Order article via Infotrieve]
  30. Baydoun, A. R., Bogle, R. G., Pearson, J. D., Mann, G. E. (1994) Br. J. Pharmacol. 112, 487-492[Abstract]
  31. Yamaji, Y., Moe, O. W., Miller, R. T., Alpern, R. J. (1994) J. Clin. Invest. 94, 1297-1303[Medline] [Order article via Infotrieve]
  32. Kaiser, S., and Curthoys, N. P. (1991) J. Biol. Chem. 266, 9397-9402[Abstract/Free Full Text]
  33. Spink, J., and Evans, T. (1997) J. Biol. Chem. 272, 24417-24425[Abstract/Free Full Text]
  34. Douvdevani, A., Abramson, O., Tamir, A., Konforty, A., Isakov, N., and Chaimovitz, C. (1995) Kidney Int. 47, 1537-1545[Medline] [Order article via Infotrieve]
  35. Bailey, J. L., Wang, X., England, B. K., Price, S. R., Ding, X., Mitch, W. E. (1996) J. Clin. Invest. 97, 1447-1453[Abstract/Free Full Text]
  36. Kopp, E. B., and Ghosh, S. (1995) Adv. Immunol. 58, 1-27[Medline] [Order article via Infotrieve]
  37. O'Connell, M. A., Cleere, R., Long, A., O'Neill, L. A. J., Kelleher, D. (1995) J. Biol. Chem. 270, 7399-7404[Abstract/Free Full Text]
  38. Melillo, G., Musso, T., Sica, A., Taylor, L. S., Cox, G. W., Varesio, L. (1995) J. Exp. Med. 182, 1683-1693[Abstract]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.